Why the study?
Atrial lead implantation poses technical challenges in patients with improper right atrial structure, where lead displacement necessitates reimplantation and increases complication risks.
The use of a specific active fixation lead (Medtronic SelectSecure 3830) may provide stable atrial placement in patients with complex right atrial anatomy and prior lead displacements.
Pre-procedural right atrial assessment may reduce lead displacement risks in heart failure; hypothesis-generating case leaves need for validation open.
<ns3:p>Atrial lead implantation commonly constitutes a technical problem, especially in patients with improper structure of the right atrium. The atrial lead displacement requires reimplantation, what creates a risk of infection and periprocedural complications, particularly in patients with the heart failure. To minimise the risk of complications, it is essential to asses potential difficulties before the procedure. The article concerns the patient with many burdens (right and left ventricular systolic dysfunction, tricuspid valve regurgitation, paroxysmal atrial fibrillation and atrial flutter, catheter ablation of both types of the arrhythmias, CRT device implantation), who was repeatedly hospitalized due to atrial lead displacement and who underwent implantation of Medtronic SelectSecure 3830 lead, what finally provided to stable placement of the lead in the right atrium.</ns3:p>
No takes yet. Share an insight, caveat, or question.
Sawicka et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: